Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

Last updated: March 3, 2025
Sponsor: Ethicon, Inc.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Urinary Incontinence

Enuresis

Genitourinary Prolapse

Treatment

Intervention

Clinical Study ID

NCT04829175
ESC_2020_03
  • Ages > 21
  • Female

Study Summary

The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS Mesh or Artisyn Mesh in women undergoing surgery for SUI and POP.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Patients who satisfy all of the following criteria will be considered eligible for enrollment in this registry:

SUI

  1. Stress urinary incontinence symptoms

  2. Urodynamic stress incontinence confirmed with urodynamic testing

  3. Female patient ≥ 21 years of age

  4. Desired surgical correction of SUI using synthetic pubo-urethral vaginal sling

  5. Planned surgery for primary SUI

  6. Patient able and willing to participate in follow-up

  7. Patient or authorized representative has signed the approved Informed consent POP

  8. Uterine or vaginal vault prolapse symptoms 2. Urodynamic testing (optional) 3. Female patient ≥ 21 years of age 4. Desired surgical correction of POP using synthetic mesh 5. Planned surgery for uterine or vaginal vault prolapse with or without concomitant SUI surgery 6. Patient able and willing to participate in follow-up 7. Patient or authorized representative has signed the approved Informed consent

Exclusion Criteria

Patients meeting any of the following criteria will be considered not eligible for enrollment in this registry:

  1. Physical or psychological condition which would impair registry participation or are unwilling or unable to participate in all required registry visits and are unable to complete the questionnaires

  2. Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of registry products

  3. History of previous synthetic, biologic or fascial sub-urethral sling (SUI) or pelvic mesh (POP)

  4. Pregnancy or plans for future pregnancy

  5. History of bleeding diathesis or current anti-coagulation therapy which cannot be suspended peri-operatively according to site's standard practice

  6. Current genitourinary fistula or urethral diverticulum

  7. Reversible cause of incontinence (i.e. drug effect) for SUI only

  8. Severe vaginal atrophy

  9. History of pelvic irradiation therapy

  10. Contraindication to surgery

Study Design

Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Intervention
Phase:
Study Start date:
April 13, 2022
Estimated Completion Date:
August 30, 2036

Connect with a study center

  • Krankenhaus der barmherzigen Schwestern

    Linz,
    Austria

    Active - Recruiting

  • General University Hospital

    Prague,
    Czechia

    Site Not Available

  • Herlev Hospital

    Hillerod,
    Denmark

    Site Not Available

  • CHU de Clermont-Ferrand

    Clermont-Ferrand,
    France

    Site Not Available

  • Hopital Jeanne de Flandres

    Lille,
    France

    Site Not Available

  • Universitatsklinikum Tubingen

    Tubingen,
    Germany

    Active - Recruiting

  • Bio-Medical University Rome

    Rome,
    Italy

    Site Not Available

  • Żelazna Medical Center

    Warsaw,
    Poland

    Site Not Available

  • Karolinska Institute

    Stockholm,
    Sweden

    Active - Recruiting

  • Yale University

    New Haven, Connecticut 06510
    United States

    Active - Recruiting

  • Duke University

    Durham, North Carolina 27707
    United States

    Active - Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania 19104
    United States

    Active - Recruiting

  • UPMC

    Pittsburgh, Pennsylvania 15213
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.